Showing results (11-20 of 1,499) with videos related to
Sort By:
Pageof 150
Applied Occupational and Environmental Hygiene|February 24, 2001
Misinterpretation and misuse of exposure limitsP HewettAmerican Industrial Hygiene Association Journal|February 1, 1995
Estimation of regional pulmonary deposition and exposure for fumes from SMAW and GMAW mild and stainless steel consumablesP HewettPhysical Review Letters|June 4, 2008
Unitary parametrization of perturbations to tribimaximal neutrino mixingSandip Pakvasa, Werner Rodejohann, Thomas J WeilerProstaglandins & Other Lipid Mediators|January 16, 2008
TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent mannerMary E Hamby, James A Hewett, Sandra J HewettGlia|July 8, 2010
Smad3-dependent signaling underlies the TGF-β1-mediated enhancement in astrocytic iNOS expressionMary E Hamby, James A Hewett, Sandra J HewettPharmacology & Therapeutics|June 6, 2006
Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous systemSandra J Hewett, Stanley C Bell, James A HewettGlia|August 22, 2006
TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2Mary E Hamby, James A Hewett, Sandra J HewettThe Journal of Pharmacology and Experimental Therapeutics|February 11, 2004
Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic windowJanna M Silakova, James A Hewett, Sandra J HewettEpilepsia|January 12, 2011
Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisitionRobert J Claycomb, Sandra J Hewett, James A HewettThe Journal of Pharmacology and Experimental Therapeutics|September 12, 2006
Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegenerationSandra J Hewett, Janna M Silakova, James A HewettPageof 150